FDA Approves Generic Singulair

The first generic forms of Singulair have been approved by the US Food and Drug Administration for treating children and adults with asthma symptoms and indoor and outdoor allergies symptoms.

The FDA said that generic versions of montelukast sodium drug will help provide more options for patients though the agency warned that it should be used to treat a sudden asthma attack as some of the side effects of montelukast were serious.

Some of the common side effects associated with the drug includes depression, mood swings, aggressions and hallucinations

Source: Medindia